Guardant Health director sells 116 shares after RSU vest
Guardant Health director Tariq Musa reported a small mix of stock transactions involving company shares.
Rhea-AI Filing Summary
Guardant Health director Tariq Musa reported a small mix of stock transactions involving company shares. On June 15, 2026, a restricted stock unit (RSU) award converted into 250 shares of common stock at a stated price of $0.00 per share, reflecting vesting of previously granted equity compensation.
The same RSU award was originally granted on March 6, 2023 and vests over four years, with 25% vesting on March 15, 2024 and the remaining 75% vesting monthly over three years. On June 16, 2026, Musa executed an open-market sale of 116 shares of common stock at an average price of $130.19 per share. Following these transactions, he holds 8,796 shares of Guardant Health common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 116 | $130.19 | $15K |
| Exercise | Restricted Stock Units | 250 | $0.00 | $0.00 |
| Exercise | Common Stock | 250 | $0.00 | $0.00 |
Footnotes (2)
- F1. The restricted stock unit award granted on March 6, 2023 vests over a four-year period. 25% of the shares subject to such award vested on March 15, 2024 and the remaining 75% vests monthly for the three-year period thereafter.
- F2. Not applicable for Restricted Stock Units.
Key Figures
Key Terms
Restricted Stock Units financial
open-market sale financial
derivative security financial
non-derivative financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Guardant Health (GH) director Tariq Musa report in this Form 4?
What RSU activity did Tariq Musa report for Guardant Health (GH)?
What is the vesting schedule of Tariq Musa’s Guardant Health (GH) RSU award?
AI-generated analysis. How Rhea-AI works. Not financial advice.